Company Search:
Advanced Search
Sponsored Links
Dimerix Ltd Company Snapshot
Dimerix Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dimerix Ltd with three other miscellaneous service companies in Australasia: Amplia Therapeutics Ltd (2020 sales of 34,227.00 Australian Dollars [US$26,511.89 ] ), Race Oncology Ltd (9,316.00 Australian Dollars [US$7,216.08 ] ), and Antisense Therapeutics Limited (30,528.00 Australian Dollars [US$23,646.68 ] ).

Sales Analysis. Sales fell dramatically in 2020: Dimerix Ltd reported sales of A$2,700.00 (US$2.09 thousand) for the fiscal year ending June of 2020. This represents a sharp decrease of 85.1% versus 2019, when the company's sales were A$18,108.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dimerix Ltd
  Stock Performance Chart for Dimerix Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/22/2021): .30
(Figures in Australian Dollars)
1 Week 25.0%   13 Weeks 30.4%  
4 Weeks 9.1%   52 Weeks 106.9%  
Dimerix Ltd Key Data:
  Ticker: DXB Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 2,700
(Year Ending Jan 2021).
Employees: 9
  Currency: Australian Dollars Market Cap: 59,324,789
  Fiscal Yr Ends: June Shares Outstanding: 197,749,297
  Share Type: Ordinary Closely Held Shares: 52,960,997
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.